Research Papers

25 of 2221 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Identification of a Notch transcriptomic signature for breast cancer.
Braune EB; Geist F; Tang X; Kalari K; Boughey J; Wang L; Leon-Ferre RA; D'Assoro AB; Ingle JN; Goetz MP; Kreis J; Wang K; Foukakis T; Seshire A; Wienke D; Lendahl U.
Breast Cancer Res (Unknown)
Published: 2024
6/6 Transparent
Data Code Registered Funding Declared
Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resis…
Tao J; Xue C; Cao M; Ye J; Sun Y; Chen H; Guan Y; Zhang W; Zhang W; Yao Y.
Breast Cancer Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR.
Breast Cancer Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Therapeutic protein PAK restrains the progression of triple negative breast cancer through degrading SREBP-1 mRNA.
Hu P; Zhou P; Sun T; Liu D; Yin J; Liu L.
Breast Cancer Res (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a pro…
Hung SK; Yang HJ; Lee MS; Liu DW; Chen LC; Chew CH; Lin CH; Lee CH; Li SC; Hong CL; Yu CC; Yu BH; Hsu FC; Chiou WY; Lin HY.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast ca…
Tan Z; Deme P; Boyapati K; Claes BSR; Duivenvoorden AAM; Heeren RMA; Tressler CM; Haughey NJ; Glunde K.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic densit…
Atakpa EC; Buist DSM; Aiello Bowles EJ; Cuzick J; Brentnall AR.
Breast Cancer Res (Unknown)
Published: 2023
5/6 Transparent
Code Registered Funding Declared
Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer.
Verschoor N; Smid M; Jager A; Sleijfer S; Wilting SM; Martens JWM.
Breast Cancer Res (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast ca…
Sharma D; Hager CG; Shang L; Tran L; Zhu Y; Ma A; Magnuson B; Lesko MW; Wicha MS; Burness ML.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin.
Franco-Valls H; Tusquets-Uxó E; Sala L; Val M; Peña R; Iaconcig A; Villarino Á; Jiménez-Arriola M; Massó P; Trincado JL; Eyras E; Muro AF; Otero J; García de Herreros A; Baulida J.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnost…
Aswolinskiy W; Munari E; Horlings HM; Mulder L; Bogina G; Sanders J; Liu YH; van den Belt-Dusebout AW; Tessier L; Balkenhol M; Stegeman M; Hoven J; Wesseling J; van der Laak J; Lips EH; Ciompi F.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cance…
Campone M; Bidard FC; Neven P; Wang L; Ling B; Dong Y; Paux G; Herold C; De Giorgi U.
Breast Cancer Res (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Blocking channels to metastasis: targeting sodium transport in breast cancer.
Brackenbury WJ; Palmieri C.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Dani…
Nielsen K; Sode M; Jensen MB; Berg T; Knoop A; Ejlertsen B; Lænkholm AV.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast …
Kazerouni AS; Peterson LM; Jenkins I; Novakova-Jiresova A; Linden HM; Gralow JR; Hockenbery DM; Mankoff DA; Porter PL; Partridge SC; Specht JM.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A catchment and location-allocation analysis of mammography access in Delaware, US: implications for disparities in geo…
Webster JL; Goldstein ND; Rowland JP; Tuite CM; Siegel SD.
Breast Cancer Res (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene …
Zhang H; Gao M; Zhao W; Yu L.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The inhibitory effect of Gremlin-2 on adipogenesis suppresses breast cancer cell growth and metastasis.
Jung J; Kim NH; Kwon M; Park J; Lim D; Kim Y; Gil W; Cheong YH; Park SA.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Circulating neutrophils from patients with early breast cancer have distinct subtype-dependent phenotypes.
Ramessur A; Ambasager B; Valle Aramburu I; Peakman F; Gleason K; Lehmann C; Papayannopoulos V; Coombes RC; Malanchi I.
Breast Cancer Res (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity.
Broeker CD; Ortiz MMO; Murillo MS; Andrechek ER.
Breast Cancer Res (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperpl…
Krisanits BA; Schuster R; Randise J; Nogueira LM; Lane JT; Panguluri GA; Li H; Helke K; Cuitiño MC; Koivisto C; Spruill L; Ostrowski MC; Anderson SM; Turner DP; Findlay VJ.
Breast Cancer Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, t…
Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M.
Breast Cancer Res (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a…
Steenbruggen TG; Wolf DM; Campbell MJ; Sanders J; Cornelissen S; Thijssen B; Salgado RA; Yau C; O-Grady N; Basu A; Bhaskaran R; Mittempergher L; Hirst GL; Coppe JP; Kok M; Sonke GS; van 't Veer LJ; Horlings HM.
Breast Cancer Res (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Native American ancestry and breast cancer risk in Colombian and Mexican women: ruling out potential confounding throug…
Zollner L; Torres D; Briceno I; Gilbert M; Torres-Mejía G; Dennis J; Bolla MK; Wang Q; Hamann U; Lorenzo Bermejo J.
Breast Cancer Res (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:…
Lundgren C; Tutzauer J; Church SE; Stål O; Ekholm M; Forsare C; Nordenskjöld B; Fernö M; Bendahl PO; Rydén L.
Breast Cancer Res (Unknown)
Published: 2023
5/6 Transparent
Data Registered Funding Declared